dr. tagawa discusses the development of immunotherapy in urothelial cancer
Published 7 years ago • 166 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
24:55
clinical development of immunotherapy in urothelial cancer
-
1:38
dr. tagawa on sacituzumab govitecan in urothelial carcinoma
-
1:31
dr. scott tagawa discusses immu-132 in patients with urothelial carcinoma
-
1:18
dr. tagawa on next steps with sacituzumab govitecan in advanced urothelial carcinoma
-
1:40
dr. tagawa on immu-132 trial updates in urothelial cancer
-
1:03
dr. pal on the sequencing of immunotherapy for urothelial carcinoma
-
0:44
role of immunotherapy in bladder cancer
-
1:11:20
controversies in cadasil with dr. michael d. geschwind
-
0:52
dr. balar discusses the impact of immunotherapy on bladder cancer
-
1:33
dr. grivas on immunotherapy in advanced urothelial cancer
-
0:48
dr. balar on the future of immunotherapy in bladder cancer
-
1:32
dr. tagawa on next steps for taxanes in prostate cancer
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
47:59
advances in bladder cancer immunotherapy, with dr. arjun balar
-
34:39
bladder cancer and immunotherapy with dr. arjun balar
-
5:50
urothelial cancer & emerging role of immunotherapy
-
0:56
scott tagawa, md, explains intravesical therapies being developed given there is a bcg shortage
-
56:13
advanced/metastatic urothelial carcinoma: understanding novel immunotherapy maintenance strategies
-
1:12
scott tagawa, md, on the study investigating nadofaragene firadenovec in bcg unresponsive nmibc